Advisors Asset Management Inc. Acquires 4,485 Shares of DaVita Inc. (NYSE:DVA)

Advisors Asset Management Inc. raised its holdings in DaVita Inc. (NYSE:DVA) by 24.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 22,686 shares of the company’s stock after buying an additional 4,485 shares during the quarter. Advisors Asset Management Inc.’s holdings in DaVita were worth $3,393,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. JPMorgan Chase & Co. lifted its stake in shares of DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 609,076 shares of the company’s stock valued at $99,846,000 after purchasing an additional 92,014 shares during the period. Amundi lifted its stake in shares of DaVita by 116.4% in the 4th quarter. Amundi now owns 446,386 shares of the company’s stock valued at $68,726,000 after purchasing an additional 240,126 shares during the period. KBC Group NV lifted its stake in shares of DaVita by 0.8% in the 4th quarter. KBC Group NV now owns 316,155 shares of the company’s stock valued at $47,281,000 after purchasing an additional 2,636 shares during the period. BNP Paribas Financial Markets lifted its stake in shares of DaVita by 23.9% in the 3rd quarter. BNP Paribas Financial Markets now owns 292,039 shares of the company’s stock valued at $47,874,000 after purchasing an additional 56,389 shares during the period. Finally, Nordea Investment Management AB lifted its stake in shares of DaVita by 4.9% in the 4th quarter. Nordea Investment Management AB now owns 264,535 shares of the company’s stock valued at $39,712,000 after purchasing an additional 12,339 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

DaVita Stock Down 0.5 %

DVA stock opened at $149.06 on Friday. DaVita Inc. has a 1-year low of $125.64 and a 1-year high of $179.60. The business has a fifty day moving average price of $158.63 and a 200-day moving average price of $157.49. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.26 and a quick ratio of 1.21. The stock has a market capitalization of $11.92 billion, a P/E ratio of 13.88, a P/E/G ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on DVA shares. Sanford C. Bernstein set a $184.00 target price on DaVita in a research note on Friday, February 21st. Barclays lifted their price objective on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Finally, Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $166.33.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.